Do not blame the SSRIs: blame the Hamilton depression rating scale

SD Østergaard - Acta neuropsychiatrica, 2018 - cambridge.org
… in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial. Acta …
The pharmacopsychometric triangle to illustrate the effectiveness of T-PEMF concomitant with …

The Hamilton rating scales for depression: a critical review of clinimetric properties of different versions

D Carrozzino, C Patierno, GA Fava… - Psychotherapy and …, 2020 - karger.com
… HAM-D17 in capturing the antidepressant effects of citalopram. In another study, Bech et al.
[… efficacy of bupropion over buspirone. Many other studies reported similar results: the HAM-…

Improving depression outcome by patient-centered medical management

AJ Rush, ME Thase - American Journal of Psychiatry, 2018 - Am Psychiatric Assoc
… to improve outcomes after ECT is no longer theoretical. One recent trial found that CBT after
a … Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. …

Illness severity and biomarkers in depression: using a unidimensional rating scale to examine BDNF

MA Caldieraro, EA Vares, LH Souza… - Comprehensive …, 2017 - Elsevier
… clinical trial results [19], and generates concern about the validity of the total 17-item HAM-D
We hypothesized that these negative results were due in part to the use of multidimensional …

A Chinese adaptation of six items, self-report Hamilton Depression Scale: factor structure and psychometric properties

XM Wang, HY Ma, J Zhong, XJ Huang, CJ Yang… - Asian Journal of …, 2022 - Elsevier
… At present, studies have proved that routine use of outcome … contain common antidepressant
side effects, which contribute … the symptoms and clinical outcomes of patients, some studies …

A review of antidepressant-induced urinary hesitancy: a focus on levomilnacipran ER including two case presentations (5633)

GM Asnis, E Caneva, MA Henderson - Expert opinion on drug …, 2016 - Taylor & Francis
… cases were part of a pivotal clinical trial using a fixed-dose … , future studies – both clinical
trials and case reports – must … Patient Rated Inventory of Side Effects which covers nine organ …

[HTML][HTML] Quantitative magnetic resonance spectroscopy of depression: The value of short-term metabolite changes in predicting treatment response

R Wang, Y Shen, G Li, R Du, A Peng - Frontiers in Neuroscience, 2022 - frontiersin.org
… , all MDD patients were treated with citalopram for 3 weeks to … to the next stage for
augmented treatment with bupropion (n … the outcome of treatment response, and our results also …

Clinician-Administered Symptom Scales Within the Basic Diagram

P Bech, P Bech - Measurement-Based Care in Mental Disorders, 2016 - Springer
… of improvement in treatment-orientated trials of patients with ordinary mental … -D 6 , we have
easy-to-use scales in measurement-based care with which to evaluate the desired effects of …

[PDF][PDF] Буспирон в практике врача-психиатра: только ли анксиолитик?

ЮВ Быков, РА Беккер - Психиатрия и психофармакотерапия, 2017 - researchgate.net
Results. ​The literature data we have found indicate that buspirone has great therapeutic
potential … in the treatment of generalized anxiety disorder, as well as an augmenting agent for …

Behandlung depressiver Störungen

M Schmauß, T Messer - Polypharmazie in der Behandlung psychischer …, 2016 - Springer
… einer AugmentationSTAR-D-Projekt zeigte die Kombination aus Citalopram und Bupropion
mit einer Remissionsrate von etwa 30% im Vergleich mit der Augmentation von Citalopram